Literature DB >> 11390466

Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.

M Maccarrone1, H Valensise, M Bari, N Lazzarin, C Romanini, A Finazzi-Agrò.   

Abstract

Physiological concentrations of progesterone stimulate the activity of the endocannabinoid-degrading enzyme anandamide hydrolase (fatty acid amide hydrolase, FAAH) in human lymphocytes. At the same concentrations, the membrane-impermeant conjugate of progesterone with BSA was ineffective, suggesting that binding to an intracellular receptor was needed for progesterone activity. Stimulation of FAAH occurred through up-regulation of gene expression at transcriptional and translational level, and was partly mediated by the Th2 cytokines. In fact, lymphocyte treatment with IL-4 or with IL-10 had a stimulating effect on FAAH, whereas the Th1 cytokines IL-12 and IFN-gamma reduced the activity and the protein expression of FAAH. Human chorionic gonadotropin or cortisol had no effect on FAAH activity. At variance with FAAH, the lymphocyte anandamide transporter and cannabinoid receptors were not affected by treatment with progesterone or cytokines. Good FAAH substrates such as anandamide and 2-arachidonoylglycerol inhibited the release of leukemia-inhibitory factor from human lymphocytes, but N-palmitoylethanolamine, a poor substrate, did not. A clinical study performed on 100 healthy women showed that a low FAAH activity in lymphocytes correlates with spontaneous abortion, whereas anandamide transporter and cannabinoid receptors in these cells remain unchanged. These results add the endocannabinoids to the hormone-cytokine array involved in the control of human pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390466     DOI: 10.4049/jimmunol.166.12.7183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.

Authors:  Mireille Alhouayek; Linda Rankin; Sandra Gouveia-Figueira; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2018-02-05       Impact factor: 8.739

Review 2.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 3.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

4.  Resveratrol protects from lipopolysaccharide-induced inflammation in the uterus and prevents experimental preterm birth.

Authors:  María Victoria Bariani; Fernando Correa; Emma Leishman; Ana Paula Domínguez Rubio; Andreína Arias; Aníbal Stern; Heather B Bradshaw; Ana María Franchi
Journal:  Mol Hum Reprod       Date:  2017-08-01       Impact factor: 4.025

Review 5.  Cannabinoids as novel anti-inflammatory drugs.

Authors:  Prakash Nagarkatti; Rupal Pandey; Sadiye Amcaoglu Rieder; Venkatesh L Hegde; Mitzi Nagarkatti
Journal:  Future Med Chem       Date:  2009-10       Impact factor: 3.808

6.  Endocannabinoid regulation in human endometrium across the menstrual cycle.

Authors:  Jessica G Scotchie; Ricardo F Savaris; Caitlin E Martin; Steven L Young
Journal:  Reprod Sci       Date:  2014-05-12       Impact factor: 3.060

7.  Trophoblast-Derived CXCL16 Decreased Granzyme B Production of Decidual γδ T Cells and Promoted Bcl-xL Expression of Trophoblasts.

Authors:  Deng-Xuan Fan; Wen-Jie Zhou; Li-Ping Jin; Ming-Qing Li; Xiang-Hong Xu; Cong-Jian Xu
Journal:  Reprod Sci       Date:  2018-06-18       Impact factor: 3.060

8.  Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.

Authors:  Carl Potenzieri; Thaddeus S Brink; Cholawat Pacharinsak; Donald A Simone
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

Review 9.  Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.

Authors:  Jessica Margaret Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Int Rev Immunol       Date:  2014-06-09       Impact factor: 5.311

Review 10.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.